Actively Recruiting
VExUS in Ards Patients and Association with AKI
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2025-02-03
120
Participants Needed
1
Research Sites
157 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
A single-center prospective observational study will be conducted with the aim of determining the prevalence of venous congestion during ARDS using venous Doppler and the VExUS score.
CONDITIONS
Official Title
VExUS in Ards Patients and Association with AKI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years old or older
- Moderate to severe ARDS according to the Berlin definition
- Requiring catecholamine support
- Receiving invasive mechanical ventilation for less than 48 hours
You will not qualify if you...
- Acute kidney injury KDIGO III needing renal replacement therapy before initial ultrasound
- Need for veno-venous or veno-arterial ECMO before inclusion
- End-stage chronic kidney disease, dialysis, or kidney transplant recipients
- History of Child C cirrhosis, liver transplant, or portal hypertension
- History of portal thrombosis
- Known pulmonary hypertension
- Pregnant women
- Patients under legal protection
- Patients opposed to participating in the research
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Armand MEKONTSO DESSAP
Créteil, Val de Marne, France, 94010
Actively Recruiting
Research Team
R
Romain ARRESTIER, PHD
CONTACT
A
Armand MEKONTSO DESSAP, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here